Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
In hemolytic diseases, such as sickle cell disease (SCD), intravascular hemolysis results in the release of hemoglobin, heme, and heme-loaded membrane microvesicles in the bloodstream. Intravascular hemolysis is thus associated with inflammation and organ injury. Complement system can be activated by heme in vitro. We investigated the mechanisms by which hemolysis and red blood cell (RBC) degradation products trigger complement activation in vivo. In kidney biopsies of SCD nephropathy patients and a mouse model with SCD, we detected tissue deposits of complement C3 and C5b-9. Moreover, drug-induced intravascular hemolysis or injection of heme or hemoglobin in mice triggered C3 deposition, primarily in kidneys. Renal injury markers (Kim-1, NGAL) were attenuated in C3-/- hemolytic mice. RBC degradation products, such as heme-loaded microvesicles and heme, induced alternative and terminal complement pathway activation in sera and on endothelial surfaces, in contrast to hemoglobin. Heme triggered rapid P selectin, C3aR, and C5aR expression and downregulated CD46 on endothelial cells. Importantly, complement deposition was attenuated in vivo and in vitro by heme scavenger hemopexin. In conclusion, we demonstrate that intravascular hemolysis triggers complement activation in vivo, encouraging further studies on its role in SCD nephropathy. Conversely, heme inhibition using hemopexin may provide a novel therapeutic opportunity to limit complement activation in hemolytic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S., Prosek, J., Nadasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,376
Complement System Part I – Molecular Mechanisms of Activation and Regulation
Merle, N. S., Church, S. E., Fremeaux-Bacchi, V., & Roumenina, L. T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00262 · Cited by 1,620
Self-citationRother, R. P., Bell, L., Hillmen, P., & Gladwin, M. T. (2005) · JAMA · doi:10.1001/jama.293.13.1653 · Cited by 1,557
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330
Complement System Part II: Role in Immunity
Merle, N. S., Noe, R., Halbwachs-Mecarelli, L., Fremeaux-Bacchi, V., & Roumenina, L. T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00257 · Cited by 1,051
Self-citationCrizanlizumab for the prevention of pain crises in sickle cell disease.
Ataga, K. I., Kutlar, A., Kanter, J., Liles, D., Cancado, R., Friedrisch, J., Guthrie, T. H., Knight-Madden, J., Alvarez, O. A., Gordeuk, V. R., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611770 · Cited by 914
Intravascular hemolysis and the pathophysiology of sickle cell disease
Kato, G. J., Steinberg, M. H., & Gladwin, M. T. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89741 · Cited by 748
Belcher, J. D., Chen, C., Nguyen, J., Milbauer, L., Abdulla, F., Alayash, A. I., Smith, A., Nath, K. A., Hebbel, R. P., & Vercellotti, G. M. (2014) · Blood · doi:10.1182/blood-2013-04-495887 · Cited by 695
Donadee, C., Raat, N. J. H., Kanias, T., Tejero, J., Lee, J. S., Kelley, E. E., Zhao, X., Liu, C., Reynolds, H., Azarov, I., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.008698 · Cited by 572
Membranoproliferative Glomerulonephritis — A New Look at an Old Entity
Sethi, S., & Fervenza, F. C. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1108178 · Cited by 565
Platelet activation leads to activation and propagation of the complement system
del Conde, I., Crúz, M. A., Zhang, H., López, J. A., & Afshar-Kharghan, V. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041497 · Cited by 397
Sickle cell disease: renal manifestations and mechanisms
Nath, K. A., & Hebbel, R. P. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.8 · Cited by 369
Belcher, J. D., Marker, P. H., Weber, J. P., Hebbel, R. P., & Vercellotti, G. M. (2000) · Blood · doi:10.1182/blood.v96.7.2451 · Cited by 367
Heme on innate immunity and inflammation
Dutra, F. F., & Bozza, M. T. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00115 · Cited by 351
Schroit, A. J., Madsen, J. W., & Tanaka, Y. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89189-x · Cited by 346
Knockout-Transgenic Mouse Model of Sickle Cell Disease
Ryan, T. M., Ciavatta, D. J., & Townes, T. M. (1997) · Science · doi:10.1126/science.278.5339.873 · Cited by 300
Baek, J. H., D’Agnillo, F., Vallelian, F., Pereira, C. P., Williams, M. C., Jia, Y., Schaer, D. J., & Buehler, P. W. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59770 · Cited by 280
van Beers, E. J., Schaap, M. C. L., Berckmans, R. J., Nieuwland, R., Sturk, A., van Doormaal, F. F., Meijers, J. C. M., Biemond, B. J., & on behalf of the CURAMA study group* (2009) · Haematologica · doi:10.3324/haematol.2009.008938 · Cited by 272
Vinchi, F., Costa da Silva, M., Ingoglia, G., Petrillo, S., Brinkman, N., Zuercher, A., Cerwenka, A., Tolosano, E., & Muckenthaler, M. U. (2016) · Blood · doi:10.1182/blood-2015-08-663245 · Cited by 269
Self-citationCamus, S. M., De Moraes, J. A., Bonnin, P., Abbyad, P., Le Jeune, S., Lionnet, F., Loufrani, L., Grimaud, L., Lambry, J.-C., Charue, D., et al. (2015) · Blood · doi:10.1182/blood-2014-07-589283 · Cited by 262
Self-citationComplement activation by heme as a secondary hit for atypical hemolytic uremic syndrome
Frimat, M., Tabarin, F., Dimitrov, J. D., Poitou, C., Halbwachs-Mecarelli, L., Fremeaux-Bacchi, V., & Roumenina, L. T. (2013) · Blood · doi:10.1182/blood-2013-03-489245 · Cited by 249
Self-citationMorigi, M., Galbusera, M., Gastoldi, S., Locatelli, M., Buelli, S., Pezzotta, A., Pagani, C., Noris, M., Gobbi, M., Stravalaci, M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100491 · Cited by 235
Vinchi, F., De Franceschi, L., Ghigo, A., Townes, T., Cimino, J., Silengo, L., Hirsch, E., Altruda, F., & Tolosano, E. (2013) · Circulation · doi:10.1161/circulationaha.112.130179 · Cited by 231
Self-citationTelen, M. J., Wun, T., McCavit, T. L., De Castro, L. M., Krishnamurti, L., Lanzkron, S., Hsu, L. L., Smith, W. R., Rhee, S., Magnani, J. L., et al. (2015) · Blood · doi:10.1182/blood-2014-06-583351 · Cited by 211
Haem transport to the liver by haemopexin. Receptor-mediated uptake with recycling of the protein
Smith, A., & Morgan, W. T. (1979) · Biochemical Journal · doi:10.1042/bj1820047 · Cited by 175
Deuel, J. W., Schaer, C. A., Boretti, F. S., Opitz, L., Garcia-Rubio, I., Baek, J. H., Spahn, D. R., Buehler, P. W., & Schaer, D. J. (2016) · Cell Death & Disease · doi:10.1038/cddis.2015.392 · Cited by 172
Heme: Modulator of Plasma Systems in Hemolytic Diseases
Roumenina, L. T., Rayes, J., Lacroix‐Desmazes, S., & Dimitrov, J. D. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.01.004 · Cited by 161
Self-citationDefective Recovery and Severe Renal Damage After Acute Hemolysis in Hemopexin-Deficient Mice
Tolosano, E., Hirsch, E., Patrucco, E., Camaschella, C., Navone, R., Silengo, L., & Altruda, F. (1999) · Blood · doi:10.1182/blood.v94.11.3906 · Cited by 149
Self-citationA prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function
Roumenina, L. T., Frimat, M., Miller, E. C., Provot, F., Dragon-Durey, M.-A., Bordereau, P., Bigot, S., Hue, C., Satchell, S. C., Mathieson, P. W., et al. (2012) · Blood · doi:10.1182/blood-2011-10-383281 · Cited by 143
Self-citationWang, R. H., Phillips, G., Medof, M. E., & Mold, C. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116706 · Cited by 139
Antibody Polyreactivity in Health and Disease: Statu Variabilis
Dimitrov, J. D., Planchais, C., Roumenina, L. T., Vassilev, T. L., Kaveri, S. V., & Lacroix‐Desmazes, S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300880 · Cited by 122
Self-citationRed blood cell vesiculation in hereditary hemolytic anemia
Alaarg, A., Schiffelers, R. M., van Solinge, W. W., & van Wijk, R. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00365 · Cited by 121
Saraf, S. L., Zhang, X., Kanias, T., Lash, J. P., Molokie, R. E., Oza, B., Lai, C., Rowe, J. H., Gowhari, M., Hassan, J., et al. (2014) · British Journal of Haematology · doi:10.1111/bjh.12690 · Cited by 120
Camus, S. M., Gausserès, B., Bonnin, P., Loufrani, L., Grimaud, L., Charue, D., Moraes, J. A., Renard, J.-M., Tedgui, A., Boulanger, C. M., et al. (2012) · Blood · doi:10.1182/blood-2012-02-413138 · Cited by 120
Self-citationDumas, G., Habibi, A., Onimus, T., Merle, J., Razazi, K., Dessap, A. M., Galactéros, F., Michel, M., Frémeaux‐Bacchi, V., Pirenne, F., et al. (2016) · Blood · doi:10.1182/blood-2015-09-669770 · Cited by 117
Detection of complement activation using monoclonal antibodies against C3d
Thurman, J. M., Kulik, L. N., Orth, H. N., Wong, M., Renner, B., Sargsyan, S. A., Mitchell, L. M., Hourcade, D. E., Hannan, J. P., Kovacs, J. M., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65861 · Cited by 98
Nephropathy associated with sickle cell anemia: An autologous immune complex nephritis
Strauss, J., Pardo, V., Koss, M. N., Griswold, W. R., & McIntosh, R. M. (1975) · The American Journal of Medicine · doi:10.1016/0002-9343(75)90604-x · Cited by 98
Nephropathy associated with sickle cell anemia: An autologous immune complex nephritis
Pardo, V., Strauss, J., Kramer, H., Ozawa, T., & McIntosh, R. M. (1975) · The American Journal of Medicine · doi:10.1016/0002-9343(75)90226-0 · Cited by 95
Pawluczkowycz, A. W., Lindorfer, M. A., Waitumbi, J. N., & Taylor, R. P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5543 · Cited by 90
Graw, J. A., Mayeur, C., Rosales, I. A., Liu, Y., Sabbisetti, V. S., Riley, F. E., Rechester, O., Malhotra, R. K., Warren, H. S., Colvin, R. B., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.019955 · Cited by 87
Dimitrov, J. D., Roumenina, L. T., Doltchinkova, V. R., Mihaylova, N. M., Lacroix-Desmazes, S., Kaveri, S. V., & Vassilev, T. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702751200 · Cited by 85
Self-citationDeuel, J., Vallelian, F., Schaer, C. A., Puglia, M., Buehler, P. W., & Schaer, D. J. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.09.016 · Cited by 77
Characterization of plasma labile heme in hemolytic conditions
Gouveia, Z., Carlos, A. R., Yuan, X., Aires‐da‐Silva, F., Stocker, R., Maghzal, G. J., Leal, S. S., Gomes, C. M., Todorovic, S., Iranzo, O., et al. (2017) · The FEBS Journal · doi:10.1111/febs.14192 · Cited by 70
van Tits, L. J., van Heerde, W. L., Landburg, P. P., Boderie, M. J., Muskiet, F. A. J., Jacobs, N. L., Duits, A. J., & Schnog, J. B. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.09.102 · Cited by 70
The role of complement activation in thrombosis and hemolytic anemias
Chapin, J. C., Terry, H., Kleinert, D. A., & Laurence, J. C. (2016) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2016.04.008 · Cited by 66
Merle, N. S., Grünenwald, A., Figueres, L., Chauvet, S., Daugan, M. V., Knockaert, S., Robe-Rybkine, T., Noé, R., May, O., Frimat, M., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00179 · Cited by 65
Self-citationVercellotti, G. M., Zhang, P., Nguyen, J., Abdulla, F. A., Chen, C., Nguyen, P., Nowotny, C., Steer, C. J., Smith, A., & Belcher, J. D. (2016) · Molecular Medicine · doi:10.2119/molmed.2016.00063 · Cited by 56
Complement Activation during Painful Crisis in Sickle Cell Anemia
Mold, C., Tamerius, J. D., & Phillips, G. (1995) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1995.1131 · Cited by 55
Hemopexin counteracts systolic dysfunction induced by heme-driven oxidative stress
Ingoglia, G., Sag, C. M., Rex, N., Franceschi, L. D., Vinchi, F., Cimino, J., Petrillo, S., Wagner, S., Kreitmeier, K., Silengo, L., et al. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.04.003 · Cited by 46
Self-citationLindorfer, M. A., Cook, E. M., Reis, E. S., Ricklin, D., Risitano, A. M., Lambris, J. D., & Taylor, R. P. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.08.017 · Cited by 24
Berg, Å., Otterdal, K., Patel, S., Gonca, M., David, C., Dalen, I., Nymo, S. H., Nilsson, M. F., Nordling, S., Magnusson, P. U., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv283 · Cited by 20
Cited by
Endothelium structure and function in kidney health and disease
Jourde-Chiche, N., Fakhouri, F., Dou, L., Bellien, J., Burtey, S., Frimat, M., Jarrot, P.-A., Kaplanski, G., Le Quintrec, M., Pernin, V., et al. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0098-z · Cited by 493
Self-citationClinical promise of next-generation complement therapeutics
Mastellos, D. C., Ricklin, D., & Lambris, J. D. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0031-6 · Cited by 343
A guide to complement biology, pathology and therapeutic opportunity
Mastellos, D. C., Hajishengallis, G., & Lambris, J. D. (2024) · Nature Reviews Immunology · doi:10.1038/s41577-023-00926-1 · Cited by 320
Metadata
- Authors
- Merle, N. S., Grunenwald, A., Rajaratnam, H., Gnemmi, V., Frimat, M., Figueres, M.-L., Knockaert, S., Bouzekri, S., Charue, D., Noe, R., Robe-Rybkine, T., Le-Hoang, M., Brinkman, N., Gentinetta, T., Edler, M., Petrillo, S., Tolosano, E., Miescher, S., Le Jeune, S., Houillier, P., Chauvet, S., Rabant, M., Dimitrov, J. D., Fremeaux-Bacchi, V., Blanc-Brude, O. P., & Roumenina, L. T.
- Venue
- JCI Insight
- Published
- 2018-06-21
- Volume
- 3
- Issue
- 12
- ISSN
- 2379-3708 (ISSN-L)
- OpenAlex
- W2809354111
- Cited by
- 189
- References
- 51
- FWCI
- 8.90
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.